We performed this study to examine whether the serum resistin concentrations in growth hormone (GH)-deficient (GHD) children are influenced by administration of GH and to assess the relationship between serum resistin and free fatty acid levels during GH replacement therapy. The study included 20 prepubertal GHD children (16 boys and 4 girls) who were treated with recombinant human GH (hGH). The serum levels of resistin, insulin-like growth factor I, free fatty acid (FFA), triglyceride, cholesterol and glucose levels, leukocyte counts, and hemoglobin A(1c) were measured at baseline and after 1 month of hGH treatment. The serum resistin levels after hGH therapy were significantly higher than the basal resistin levels (median [range], 6.2 [4.9-11.8] vs 5.6 [4.4-8.3] ng/mL; P < .05), whereas the serum FFA levels were unchanged before and after treatment (0.51 [0.34-0.76] vs 0.37 [0.24-0.60] mEq/L). No significant relationship was found between serum resistin and FFA levels after hGH therapy. Body mass index, serum triglyceride, cholesterol and glucose levels, leukocyte counts, and hemoglobin A(1c) showed no significant differences before and after hGH treatment. Our results suggest that elevated serum resistin levels after 1-month hGH therapy in GHD children are not associated with the GH-induced lipolysis as found in GHD adults during short-time hGH therapy.
Serum resistin concentrations in growth hormone-deficient children during growth hormone replacement therapy. Publishing Authors By Initials
Serum resistin concentrations in growth hormone-deficient children during growth hormone replacement therapy. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Metabolism: clinical and experimental
VOLUME: 56
Page Numbers: 1514-7
Journal Abbreviation: Metab. Clin. Exp.
ISSN: 0026-0495
DAY: 22
MONTH: Nov
YEAR: 2007
Serum resistin concentrations in growth hormone-deficient children during growth hormone replacement therapy. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 375267
Serum resistin concentrations in growth hormone-deficient children during growth hormone replacement therapy. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Serum resistin concentrations in growth hormone-deficient children during growth hormone replacement therapy. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Serum resistin concentrations in growth hormone-deficient children during growth hormone replacement therapy.
AFFILIATION: Department of Pediatrics, Tsukuba Medical Center Hospital, Ibaraki 305-8558, Japan. nozueh@xd5.so-net.ne.jp
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Metabolism
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Serum resistin concentrations in growth hormone-deficient children during growth hormone replacement therapy Related Publications